avoid tpa in malignant pleural effusion with increased bleeding risks


Cancers with hematologic spread have increased bleeding risk. When managing malignant pleural effusion with these cancers, TPA can lead to increased bleeding.

Some examples include follicular thyroid, renal cell, etc.

Reduce TPA to 1/2 for increased bleeding risks.